| |
| [ JPM Week SF 2026 ] |
Biopharma Foundational Reset
|
| With Tony Wood (Chief Scientific Officer, GSK), Mike Doustdar (CEO, Novo Nordisk), Heather Turner (CEO, LB Pharma), Fred Ramsdell (Nobel Laureate), Robert Nelsen (ARCH VC). |
| Marriott Marquis, 780 Mission St, San Francisco |
|
Jan 12 (Mon) , 2026 @ 07:00 AM
| |
$875 |
|
|
|
|
|
|
|
|
| |
| DETAILS |
|
Each new biopharma year doesn't start on January 1 - it kicks off a few weeks later when leaders gather in San Francisco. The annual JPM event sets the tone for a year of dealmaking, & in 2026, leaders will make sense of the industry's instability & set the course forward.
Endpoints journalists will join industry leaders on stage, pushing for real answers that cut through the usual talking points. We'll focus on the systemic forces that are reshaping the industry, including China's emerging role in innovation, regulatory shifts under the new administration, & the volatile market environment.
And the Endpoints Hub will give you a place to step back from the frenzy - space for meetings, perspective, & connection.
People
Real people, real conversations, real answers - get the full story from leaders on where we go from here.
Programming
Candid discussions about what actually works when funding plateaus & barriers keep rising.
Place
The Endpoints Hub, a coworking space that offers sanctuary to meet, focus, & connect in the midst of the JPM frenzy.
|
|
|
|
|
|
|
|
